TGFB1 and ovarian carcinoma: In the context of ovarian cancer, the tumor microenvironment (TME) becomes enriched with immunosuppressive mediators, notably mucins and transforming growth factor-β (TGF-β), which significantly compromise the cytotoxic potential of natural killer (NK) cells.